CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test.

Accurate differential diagnosis of the precise cause of Cushing's syndrome can be difficult, and conventional tests such as those based on the use of dexamethasone may be misleading. We have therefore studied the cortisol and ACTH responses to ovine corticotrophin-releasing factor (CRF-41) in 2...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Grossman, AB, Howlett, T, Perry, L, Coy, D, Savage, M, Lavender, P, Rees, L, Besser, G
Định dạng: Journal article
Ngôn ngữ:English
Được phát hành: 1988
_version_ 1826296696325275648
author Grossman, AB
Howlett, T
Perry, L
Coy, D
Savage, M
Lavender, P
Rees, L
Besser, G
author_facet Grossman, AB
Howlett, T
Perry, L
Coy, D
Savage, M
Lavender, P
Rees, L
Besser, G
author_sort Grossman, AB
collection OXFORD
description Accurate differential diagnosis of the precise cause of Cushing's syndrome can be difficult, and conventional tests such as those based on the use of dexamethasone may be misleading. We have therefore studied the cortisol and ACTH responses to ovine corticotrophin-releasing factor (CRF-41) in 28 consecutive patients with Cushing's syndrome, and compared the diagnostic value of this test with that of the high-dose dexamethasone suppression test (8 mg/day for 48 h). Of 20 patients with confirmed Cushing's disease (pituitary-dependent Cushing's syndrome), only 16 (80%) showed the expected 50% or more suppression of serum cortisol following high-dose dexamethasone administration. Four patients each with adrenal adenomas and three patients with the ectopic ACTH syndrome failed to suppress, while a child with probable Cushing's disease showed a variable response depending on the dose used. Following CRF stimulation, 15 out of the 20 patients (75%) with Cushing's disease showed an excessive rise in serum cortisol, outside the normal range, while in five the response to CRF-41 was normal on at least one occasion. None of the patients with adrenal adenomas or the ectopic ACTH syndrome showed a cortisol response to CRF. Thus, either test on its own may be misleading in differentiating Cushing's disease from other causes of the syndrome. Every patient with Cushing's disease, however, showed either suppression in response to high-dose dexamethasone or an excessive cortisol response to CRF testing. It appears, therefore, that the combination of the high-dose dexamethasone and the CRF test, with measurement of serum cortisol, is superior to either test alone in the differential diagnosis of Cushing's syndrome.
first_indexed 2024-03-07T04:20:19Z
format Journal article
id oxford-uuid:cacc602c-e464-40f8-a617-da3a370d78b5
institution University of Oxford
language English
last_indexed 2024-03-07T04:20:19Z
publishDate 1988
record_format dspace
spelling oxford-uuid:cacc602c-e464-40f8-a617-da3a370d78b52022-03-27T07:10:01ZCRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:cacc602c-e464-40f8-a617-da3a370d78b5EnglishSymplectic Elements at Oxford1988Grossman, ABHowlett, TPerry, LCoy, DSavage, MLavender, PRees, LBesser, GAccurate differential diagnosis of the precise cause of Cushing's syndrome can be difficult, and conventional tests such as those based on the use of dexamethasone may be misleading. We have therefore studied the cortisol and ACTH responses to ovine corticotrophin-releasing factor (CRF-41) in 28 consecutive patients with Cushing's syndrome, and compared the diagnostic value of this test with that of the high-dose dexamethasone suppression test (8 mg/day for 48 h). Of 20 patients with confirmed Cushing's disease (pituitary-dependent Cushing's syndrome), only 16 (80%) showed the expected 50% or more suppression of serum cortisol following high-dose dexamethasone administration. Four patients each with adrenal adenomas and three patients with the ectopic ACTH syndrome failed to suppress, while a child with probable Cushing's disease showed a variable response depending on the dose used. Following CRF stimulation, 15 out of the 20 patients (75%) with Cushing's disease showed an excessive rise in serum cortisol, outside the normal range, while in five the response to CRF-41 was normal on at least one occasion. None of the patients with adrenal adenomas or the ectopic ACTH syndrome showed a cortisol response to CRF. Thus, either test on its own may be misleading in differentiating Cushing's disease from other causes of the syndrome. Every patient with Cushing's disease, however, showed either suppression in response to high-dose dexamethasone or an excessive cortisol response to CRF testing. It appears, therefore, that the combination of the high-dose dexamethasone and the CRF test, with measurement of serum cortisol, is superior to either test alone in the differential diagnosis of Cushing's syndrome.
spellingShingle Grossman, AB
Howlett, T
Perry, L
Coy, D
Savage, M
Lavender, P
Rees, L
Besser, G
CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test.
title CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test.
title_full CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test.
title_fullStr CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test.
title_full_unstemmed CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test.
title_short CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test.
title_sort crf in the differential diagnosis of cushing s syndrome a comparison with the dexamethasone suppression test
work_keys_str_mv AT grossmanab crfinthedifferentialdiagnosisofcushingssyndromeacomparisonwiththedexamethasonesuppressiontest
AT howlettt crfinthedifferentialdiagnosisofcushingssyndromeacomparisonwiththedexamethasonesuppressiontest
AT perryl crfinthedifferentialdiagnosisofcushingssyndromeacomparisonwiththedexamethasonesuppressiontest
AT coyd crfinthedifferentialdiagnosisofcushingssyndromeacomparisonwiththedexamethasonesuppressiontest
AT savagem crfinthedifferentialdiagnosisofcushingssyndromeacomparisonwiththedexamethasonesuppressiontest
AT lavenderp crfinthedifferentialdiagnosisofcushingssyndromeacomparisonwiththedexamethasonesuppressiontest
AT reesl crfinthedifferentialdiagnosisofcushingssyndromeacomparisonwiththedexamethasonesuppressiontest
AT besserg crfinthedifferentialdiagnosisofcushingssyndromeacomparisonwiththedexamethasonesuppressiontest